Track Allakos Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

Allakos Inc. ALLK · Stock Open Allakos Inc. in new tab

0.3291 USD
Add to portfolio
EPS
-0.78
P/B
0.54
ROE
-88.88
Beta
0.14
1M 6M YTD 1Y 2Y 5Y Max
Loading chart...
Key Metrics
Earnings dateNov. 4, 2025
EPS-0.78
Book Value0.61
Price to Book0.54
% Insiders1.963%
Estimates
Forward P/E-0.52
Forward EPS-0.63

DCF Valuation

Tweak assumptions to recompute fair value for Allakos Inc. (ALLK)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result
Fair Value (DCF)
—
Current Price
—
Upside
—
WACC
—
Terminal PV
—
Σ PV of FCFs
—
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

Allakos Inc. Logo Allakos Inc. Analysis (ALLK)

United States Health Care Official Website Stock

Is Allakos Inc. a good investment? Allakos Inc. (ALLK) is currently trading at 0.3291 USD.

Earnings Schedule: Allakos Inc. is expected to release its next earnings report on Nov. 4, 2025. The market consensus estimate for Forward EPS is -0.63.

Investor FAQ

Does Allakos Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is Allakos Inc.?

Allakos Inc. is classified as a Stock. You can compare it against 6 other assets in the "Related Symbols" list on this page.

When is the next earnings date?

The next earnings date is projected to be Nov. 4, 2025. The company currently has a trailing EPS of -0.78.

Company Profile

As of May 15, 2025, operates as a subsidiary of Concentra Biosciences, LLC.

Exchange Ticker
BER (Germany) 37Z.BE
DUS (Germany) 37Z.DU
NMS (United States) ALLK
FRA (Germany) 37Z.F
MUN (Germany) 37Z.MU
STU (Germany) 37Z.SG
Trades
No dividend information available for this instrument.
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion